Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yuquan Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-1149-4674; OpenAlex author ID A5101319226. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts. Co-author DOI 10.1016/j.isci.2024.111693↗
  2. Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literature review. Co-author DOI 10.21037/hbsn-24-282↗
  3. Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcin… Co-author DOI 10.1097/js9.0000000000001293↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaxiang Xu · 3 shared papers, 2024–2025 · strength 0.63
  2. Haokang Feng · 2 shared papers, 2025 · strength 0.43
  3. Xu Han · 2 shared papers, 2025 · strength 0.43
  4. Jianang Li · 2 shared papers, 2024–2025 · strength 0.41
  5. Yaolin Xu · 1 shared paper, 2025 · strength 0.22
  6. Weisheng Yu · 1 shared paper, 2025 · strength 0.22
  7. Dansong Wang · 1 shared paper, 2025 · strength 0.22
  8. Wenhui Lou · 1 shared paper, 2025 · strength 0.22
  9. Hanlin Yin · 1 shared paper, 2025 · strength 0.21
  10. Liang Liu · 1 shared paper, 2025 · strength 0.21
  11. Hua Su · 1 shared paper, 2025 · strength 0.21
  12. Lei Zhang · 1 shared paper, 2025 · strength 0.21
  13. Runjie Liu · 1 shared paper, 2025 · strength 0.21
  14. Wenhui Lou · 1 shared paper, 2025 · strength 0.21
  15. Liang Liu · 1 shared paper, 2024 · strength 0.20
  16. Wenquan Wang · 1 shared paper, 2024 · strength 0.20
  17. Zijin Xu · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.